SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 38 filers reported holding SINOVAC BIOTECH LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,328 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q2 2023 | $179,328 | +0.2% | 27,717 | 0.0% | 0.00% | – |
| Q3 2022 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q2 2022 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q4 2021 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q3 2021 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q2 2021 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q1 2021 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q4 2020 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q3 2020 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q2 2020 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q1 2020 | $179,000 | -50.0% | 27,717 | -50.0% | 0.00% | – |
| Q4 2019 | $358,000 | +100.0% | 55,434 | +100.0% | 0.00% | – |
| Q3 2019 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q2 2019 | $179,000 | 0.0% | 27,717 | 0.0% | 0.00% | – |
| Q1 2019 | $179,000 | -53.4% | 27,717 | -50.0% | 0.00% | – |
| Q4 2018 | $384,000 | +80.3% | 55,434 | +100.0% | 0.00% | – |
| Q3 2018 | $213,000 | +3.4% | 27,717 | 0.0% | 0.00% | – |
| Q2 2018 | $206,000 | -13.4% | 27,717 | 0.0% | 0.00% | – |
| Q1 2018 | $238,000 | +9.2% | 27,717 | 0.0% | 0.00% | – |
| Q4 2017 | $218,000 | +11.8% | 27,717 | 0.0% | 0.00% | – |
| Q3 2017 | $195,000 | -15.9% | 27,717 | -19.6% | 0.00% | – |
| Q2 2017 | $232,000 | +3.1% | 34,487 | -12.6% | 0.00% | – |
| Q1 2017 | $225,000 | +40.6% | 39,476 | +45.3% | 0.00% | – |
| Q4 2016 | $160,000 | +16.8% | 27,170 | +16.6% | 0.00% | – |
| Q3 2016 | $137,000 | 0.0% | 23,297 | +0.7% | 0.00% | – |
| Q2 2016 | $137,000 | -6.8% | 23,139 | 0.0% | 0.00% | – |
| Q1 2016 | $147,000 | +10.5% | 23,139 | -0.7% | 0.00% | – |
| Q4 2015 | $133,000 | +14.7% | 23,297 | +1.4% | 0.00% | – |
| Q3 2015 | $116,000 | -1.7% | 22,981 | +1.4% | 0.00% | – |
| Q2 2015 | $118,000 | +37.2% | 22,665 | +29.5% | 0.00% | – |
| Q1 2015 | $86,000 | -3.4% | 17,499 | +2.8% | 0.00% | – |
| Q4 2014 | $89,000 | +67.9% | 17,025 | +52.3% | 0.00% | – |
| Q3 2014 | $53,000 | -10.2% | 11,180 | +5.8% | 0.00% | – |
| Q2 2014 | $59,000 | -23.4% | 10,564 | -1.5% | 0.00% | – |
| Q1 2014 | $77,000 | +24.2% | 10,722 | +4.6% | 0.00% | – |
| Q4 2013 | $62,000 | – | 10,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |